Literature DB >> 25749664

The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema.

Yochai Adir1, Jacob E Ollech, Baruch Vainshelboim, Yael Shostak, Arie Laor, Mordechai R Kramer.   

Abstract

PURPOSE: Mild pulmonary hypertension (PH) in patients with advanced COPD is common, but its effects on exercise capacity are controversial. The objective of our study was to investigate the effects of mild PH (35 > mPAP ≥ 25 mmHg) on exercise capacity in patients with advanced emphysema, candidates for lung transplantation.
METHODS: We retrospectively reviewed and compare the data from right heart catheterization and cardiopulmonary exercise test, performed in patients with advanced emphysema, candidate for lung transplantation.
RESULTS: Twenty patients with emphysema and no PH and 24 patients with emphysema associated with mild PH included in the study. Both patient groups had severe airways obstruction with markedly reduced FEV1 (24.9% P ± 8.9 and 25.9% P ± 11.7, respectively), and severely reduced DLCO (35.2% P ± 17.3 and 39.2% P ± 15.9). Both patients group demonstrated mark reduction in maximum workload and peak VO2 together with increased ventilatory equivalent for CO2 and extremely low breathing reserve. There was no correlation between mPAP and any of the exercise measurement.
CONCLUSIONS: Our study suggests that exercise capacity in patients with advanced emphysema is limited by the ventilatory impairment and the presence of mild PH has no farther impact on exercise capability.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25749664     DOI: 10.1007/s00408-015-9698-6

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  31 in total

1.  The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles.

Authors:  Andrea Aliverti; Peter T Macklem
Journal:  J Appl Physiol (1985)       Date:  2008-03-20

Review 2.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

3.  Right ventricular dysfunction and the exercise limitation of chronic obstructive pulmonary disease.

Authors:  D A Morrison; K Adcock; C M Collins; S Goldman; J H Caldwell; M I Schwarz
Journal:  J Am Coll Cardiol       Date:  1987-06       Impact factor: 24.094

4.  Patterns of cardiovascular dysfunction in chronic obstructive lung disease.

Authors:  B Burrows; L J Kettel; A H Niden; M Rabinowitz; C F Diener
Journal:  N Engl J Med       Date:  1972-04-27       Impact factor: 91.245

5.  Exercise pathophysiology in patients with primary pulmonary hypertension.

Authors:  X G Sun; J E Hansen; R J Oudiz; K Wasserman
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

6.  Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension.

Authors:  Bart G Boerrigter; Harm J Bogaard; Pia Trip; Herman Groepenhoff; Heleen Rietema; Sebastiaan Holverda; Anco Boonstra; Pieter E Postmus; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

7.  Ambulatory pulmonary artery pressure monitoring during sleep and exercise in normal individuals and patients with COPD.

Authors:  D A Raeside; A Brown; K R Patel; D Welsh; A J Peacock
Journal:  Thorax       Date:  2002-12       Impact factor: 9.139

8.  Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.

Authors:  J Travers; P Laveneziana; K A Webb; S Kesten; D E O'Donnell
Journal:  Respir Med       Date:  2007-05-01       Impact factor: 3.415

9.  Aerobic exercise capacity in COPD patients with and without pulmonary hypertension.

Authors:  Céline Pynnaert; Michel Lamotte; Robert Naeije
Journal:  Respir Med       Date:  2009-07-03       Impact factor: 3.415

10.  Right ventricular function at rest and during exercise in chronic obstructive pulmonary disease. Comparison of two radionuclide techniques.

Authors:  R M Oliver; J S Fleming; D G Waller
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

View more
  2 in total

1.  Accuracy of CT Pulmonary Artery Diameter for Pulmonary Hypertension in End-Stage COPD.

Authors:  Firdaus A Mohamed Hoesein; Tim Besselink; Esther Pompe; Erik-Jan Oudijk; Ed A de Graaf; J M Kwakkel-van Erp; Pim A de Jong; Bart Luijk
Journal:  Lung       Date:  2016-07-16       Impact factor: 2.584

2.  Cardiopulmonary exercise test and PaO2 in evaluation of pulmonary hypertension in COPD.

Authors:  Ingunn Skjørten; Janne Mykland Hilde; Morten Nissen Melsom; Jonny Hisdal; Viggo Hansteen; Kjetil Steine; Sjur Humerfelt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.